Common Contracts

4 similar Convertible Security Agreement contracts by Psyence Biomedical Ltd.

SENIOR SECURED CONVERTIBLE NOTE
Convertible Security Agreement • July 23rd, 2024 • Psyence Biomedical Ltd. • Pharmaceutical preparations • New York

THIS SENIOR SECURED CONVERTIBLE NOTE is a duly authorized and validly issued Convertible Promissory Note of Psyence Biomedical Ltd., a corporation existing under the laws of Ontario, Canada (the “Company”), having its principal place of business at 121 Richmond Street West, Penthouse Suite 1300, Toronto, Ontario M5H 2K1 designated as its Convertible Note due July 15th, 2027 (this “Note”).

AutoNDA by SimpleDocs
SENIOR SECURED CONVERTIBLE NOTE DUE JUNE 14th, 2027
Convertible Security Agreement • June 20th, 2024 • Psyence Biomedical Ltd. • Pharmaceutical preparations • New York

THIS SENIOR SECURED CONVERTIBLE NOTE is a duly authorized and validly issued Convertible Promissory Note of Psyence Biomedical Ltd., a corporation existing under the laws of Ontario, Canada (the “Company”), having its principal place of business at 121 Richmond Street West, Penthouse Suite 1300, Toronto, Ontario M5H 2K1 designated as its Convertible Note due January 25th, 2027 (this “Note”).

SENIOR SECURED CONVERTIBLE NOTE DUE JANUARY 25th, 2027
Convertible Security Agreement • June 6th, 2024 • Psyence Biomedical Ltd. • Pharmaceutical preparations • New York

THIS SENIOR SECURED CONVERTIBLE NOTE is a duly authorized and validly issued Convertible Promissory Note of Psyence Biomedical Ltd., a corporation existing under the laws of Ontario, Canada (the “Company”), having its principal place of business at 121 Richmond Street West, Penthouse Suite 1300, Toronto, Ontario M5H 2K1 designated as its Convertible Note due January 25th, 2027 (this “Note”).

FORM OF SENIOR SECURED CONVERTIBLE NOTE
Convertible Security Agreement • January 31st, 2024 • Psyence Biomedical Ltd. • Pharmaceutical preparations • New York

THIS SENIOR SECURED CONVERTIBLE NOTE is a duly authorized and validly issued Convertible Promissory Note of Psyence Biomedical Ltd., a corporation existing under the laws of Ontario, Canada (the “Company”), having its principal place of business at ________________ designated as its Convertible Note due January__, 2027 (this “Note”).

Draft better contracts in just 5 minutes Get the weekly Law Insider newsletter packed with expert videos, webinars, ebooks, and more!